...
首页> 外文期刊>British Journal of Haematology >Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma
【24h】

Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma

机译:单核苷酸多态性阵列为移植后弥漫性大B细胞淋巴瘤的发病机理提供新的见解

获取原文
   

获取外文期刊封面封底 >>

       

摘要

SummaryPost-transplant lymphoproliferative disorders (PTLD) are complications of solid organ transplantation associated with severe morbidity and mortality. Diffuse large B-cell lymphoma (DLBCL) represents the most common form of monomorphic PTLD. We studied 44 cases of post-transplant DLBCL (PT-DLBCL) with high-density genome wide single nucleotide polymorphism-based arrays, and compared them with 105 cases of immunocompetent DLBCL (IC-DLBCL) and 28 cases of Human Immunodeficiency Virus-associated DLBCL (HIV-DLBCL). PT-DLBCL showed a genomic profile with specific features, although their genomic complexity was overall similar to that observed in IC- and HIV-DLBCL. Among the loci more frequently deleted in PT-DLBCL there were small interstitial deletions targeting known fragile sites, such as FRA1B, FRA2E and FRA3B. Deletions at 2p16.1 (FRA2E) were the most common lesions in PT-DLBCL, occurring at a frequency that was significantly higher than in IC-DLBCL. Genetic lesions that characterized post-germinal center IC-DLBCL were under-represented in our series of PT-DLBCL. Two other differences between IC-DLBCL and PT-DLBCL were the lack of del(13q14.3) (MIR15/MIR16) and of copy neutral LOH affecting 6p [major histocompatibility complex (MHC) locus] in the latter group. In conclusion, PT-DLBCL presented unique features when compared with IC-DLBCL. Changes in PT-DLBCL were partially different to those in HIV-DLBCL, suggesting different pathogenetic mechanisms in the two conditions linked to immunodeficiency.
机译:总结移植后淋巴增生性疾病(PTLD)是实体器官移植的并发症,伴有严重的发病率和死亡率。弥漫性大B细胞淋巴瘤(DLBCL)代表单形PTLD的最常见形式。我们研究了44例具有高密度全基因组单核苷酸多态性阵列的移植后DLBCL(PT-DLBCL),并将它们与105例具有免疫功能的DLBCL(IC-DLBCL)和28例与人类免疫缺陷病毒相关的病例进行比较DLBCL(HIV-DLBCL)。 PT-DLBCL显示出具有特定特征的基因组概况,尽管它们的基因组复杂性总体上与在IC-和HIV-DLBCL中观察到的相似。在PT-DLBCL中更频繁删除的基因座中,有针对已知易碎位点(如FRA1B,FRA2E和FRA3B)的小间隙缺失。 2p16.1(FRA2E)缺失是PT-DLBCL中最常见的病变,其发生频率显着高于IC-DLBCL。在我们的PT-DLBCL系列中,以发芽后中心IC-DLBCL为特征的遗传性病变的代表性不足。 IC-DLBCL和PT-DLBCL之间的两个其他区别是,缺少del(13q14.3)(MIR15 / MIR16)和复制中性LOH影响了后者的6p [主要组织相容性复合体(MHC)基因座]。总之,与IC-DLBCL相比,PT-DLBCL具有独特的功能。 PT-DLBCL的变化与HIV-DLBCL的变化部分不同,表明在与免疫缺陷有关的两种情况下,不同的致病机制。

著录项

  • 来源
    《British Journal of Haematology》 |2010年第4期|p.569-577|共9页
  • 作者单位

    Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland;

    Division of Haematology, Department of Clinical and Experimental Medicine & BRMA, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;

    Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland;

    Department of Pathology and Microbiology, University of Nebraska, Omaha, NE;

    Department of Pathology and Microbiology, University of Nebraska, Omaha, NE;

    Institute for Cancer Genetics and Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA;

    Division of Haematology, Department of Clinical and Experimental Medicine & BRMA, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;

    Divisions of Pathology and Haematology, Ospedale Niguarda Ca’ Granda, Milan;

    Department of Pathology, IRCCS Policlinico San Matteo/University of Pavia, Pavia;

    Division of Haematology, Ospedali Riuniti, Bergamo, Italy;

    Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland|Istituto Dalle Molle di Studi sull’Intelligenza Artificiale (IDSIA), Manno, Switzerland;

    Department of Biomedical Science and Human Oncology, Center of Experimental Medicine and Research (CeRMS), University of Turin, Turin;

    Pathology Unit & Unit of Lymphoid Malignancies, San Raffaele H Scientific Institute Milan, Italy;

    Programa de Patologia Molecular, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain;

    Programa de Patologia Molecular, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain;

    Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland;

    Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland;

    Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland;

    Institute for Cancer Genetics and Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA;

    Division of Haematology, Department of Clinical and Experimental Medicine & BRMA, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;

    Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland|Istituto Dalle Molle di Studi sull’Intelligenza Artificiale (IDSIA), Manno, Switzerland;

    Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

    Affymetrix; comparative genomic hybridization; diffuse large B-cell lymphoma; human immunodeficiency virus; immunodeficiency; solid organ transplant;

    机译:Affymetrix;比较基因组杂交;弥漫性大B细胞淋巴瘤;人免疫缺陷病毒;免疫缺陷;实体器官移植;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号